Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

Moderna Begins Phase 3 Of Its COVID-19 Vaccine Trial

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses a trial for Moderna's experimental mRNA COVID-19 vaccine, involving 30,000 volunteers. Unlike traditional vaccines, it uses mRNA to trigger an immune response. Participants receive either the vaccine or a placebo, and researchers monitor them for COVID-19 infections. Moderna aims to produce up to 1 billion doses by 2021, with potential protection lasting up to two years.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF